2950-3272

Blood Vessels Thrombosis & Hemostasis

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 186 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact186 DOIs
2

Deposit reference lists for 11 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact11 DOIs
3

Attach ORCID iDs across 4 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact4 DOIs

DOIs for this ISSN

Showing the top 5 of 186 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Targeting the P-selectin/PSGL-1 pathway: discovery of diseas… (10.1016/j.bvth.2024.100015)
Abstract
36.18 27
2 ECMO-induced coagulopathy: strategic initiatives for researc… (10.1016/j.bvth.2025.100064)
Abstract
33.56 21
3 Efficacy of vitamin C with Fe supplementation in patients wi… (10.1016/j.bvth.2024.100023)
Abstract
31.97 18
4 EASIX and m-EASIX predict severe cytokine release syndrome a… (10.1016/j.bvth.2024.100025)
Abstract
28.65 13
5 In vivo neuroprotection in ischemic stroke by activated prot… (10.1016/j.bvth.2024.100037)
Abstract
26.98 11
6 Understanding the structure of β2-glycoprotein I: new insigh… (10.1016/j.bvth.2024.100041)
Abstract
25.00 9
7 Challenges with measuring tissue factor antigen and activity… (10.1016/j.bvth.2024.100022)
Abstract
23.86 8
8 Cardiovascular risk factors in myeloproliferative neoplasms:… (10.1016/j.bvth.2025.100051)
Abstract
23.86 8
9 Clinical characteristics and outcomes of acquired hemophilia… (10.1016/j.bvth.2024.100027)
Abstract
21.13 6
10 Human and mouse platelet transcriptomes and proteomes for ph… (10.1016/j.bvth.2025.100068)
Abstract
21.13 6
11 Procoagulant off-target effect of the direct oral anticoagul… (10.1016/j.bvth.2025.100100)
Abstract
21.13 6
12 Alpelisib, a PI3Kα inhibitor, effectively treats vascular an… (10.1016/j.bvth.2025.100133)
Abstract
21.13 6
13 Structural basis of MPL activation by thrombopoietin (10.1016/j.bvth.2024.100018)
Abstract
19.45 5
14 Altered shear stress of blood flow causes plasma membrane da… (10.1016/j.bvth.2024.100040)
Abstract
19.45 5
15 Elevated tissue factor pathway inhibitor delays thrombin gen… (10.1016/j.bvth.2025.100071)
Abstract
19.45 5
16 Bacterial infection and activation of the contact pathway of… (10.1016/j.bvth.2025.100091)
Abstract
19.45 5
17 Comprehensive assessment of endothelial dysfunction before c… (10.1016/j.bvth.2025.100105)
Abstract
19.45 5
18 A multicellular vessel-on-a-chip model reveals context-depen… (10.1016/j.bvth.2024.100007)
Abstract
17.47 4
19 Tailoring caplacizumab administration using ADAMTS13 activit… (10.1016/j.bvth.2024.100010)
Abstract
17.47 4
20 Trauma-induced dysfibrinogenemia: the von Clauss assay does… (10.1016/j.bvth.2024.100017)
Abstract
17.47 4
21 Cellular and enzymatic features of thrombi in humans are vas… (10.1016/j.bvth.2024.100029)
Abstract
17.47 4
22 Unfolded von Willebrand factor binds protein S and reduces a… (10.1016/j.bvth.2024.100030)
Abstract
17.47 4
23 Artificial intelligence meets venous thromboembolism: inform… (10.1016/j.bvth.2024.100031)
Abstract
17.47 4
24 Acquired (autoimmune) hemophilia: demographics, outcomes, an… (10.1016/j.bvth.2025.100062)
Abstract
17.47 4
25 From theory to platelets: unraveling the history and complex… (10.1016/j.bvth.2025.100073)
Abstract
17.47 4
26 Risk factors for anticoagulant-related bleeding in cancer: t… (10.1016/j.bvth.2025.100116)
Abstract
17.47 4
27 Angiopoietin-2 is associated with sickle cell complications,… (10.1016/j.bvth.2024.100001)
Abstract
15.05 3
28 Real-world insights on the management of immune-mediated thr… (10.1016/j.bvth.2024.100008)
Abstract
15.05 3
29 Vascular biomarkers reveal a unique toxicity profile of post… (10.1016/j.bvth.2024.100020)
Abstract
15.05 3
30 Low incidence of thromboembolism with Fiix-monitored warfari… (10.1016/j.bvth.2025.100056)
Abstract
15.05 3
31 Real-world analysis of strategies to prevent thrombosis and… (10.1016/j.bvth.2025.100065)
Abstract
15.05 3
32 Platelet recruitment kinetics are impacted by von Willebrand… (10.1016/j.bvth.2025.100076)
Abstract
15.05 3
33 M protein and the evolving spectrum of platelet-activating a… (10.1016/j.bvth.2025.100093)
Abstract
15.05 3
34 Neutrophils are key modulators of sex differences in LPS-ind… (10.1016/j.bvth.2025.100104)
Abstract
15.05 3
35 Evaluating research collaboration networks among venous thro… (10.1016/j.bvth.2024.100004)
Abstract
11.93 2
36 Clusterin can mediate apoptosis-induced molecular mechanisms… (10.1016/j.bvth.2024.100012)
Abstract
11.93 2
37 Role of azathioprine in the management of ITP in the TPO-RA… (10.1016/j.bvth.2024.100035)
Abstract
11.93 2
38 Screening for gene variants causing inherited platelet disor… (10.1016/j.bvth.2024.100043)
Abstract
11.93 2
39 Risk factors for joint bleeding in severe hemophilia A and B… (10.1016/j.bvth.2025.100047)
Abstract
11.93 2
40 Kinetics of DNases after hematopoietic stem cell transplant (10.1016/j.bvth.2025.100055)
Abstract
11.93 2
41 C-reactive protein and the menstrual cycle in females with s… (10.1016/j.bvth.2025.100067)
Abstract
11.93 2
42 Quantifying the unique mechanical properties of irreversibly… (10.1016/j.bvth.2025.100077)
Abstract
11.93 2
43 A novel in vitro model of trauma-induced endotheliopathy pro… (10.1016/j.bvth.2025.100087)
Abstract
11.93 2
44 How genetic advances are being translated into improved diag… (10.1016/j.bvth.2025.100090)
Abstract
11.93 2
45 Multiomics reveal plasma constituents associated with thromb… (10.1016/j.bvth.2025.100102)
Abstract
11.93 2
46 Impact of anticoagulation on quality of life in patients wit… (10.1016/j.bvth.2025.100112)
Abstract
11.93 2
47 Automated natural language processing to identify venous thr… (10.1016/j.bvth.2025.100122)
Abstract
11.93 2
48 Distinct endothelial cell toxicities of Abl tyrosine kinase… (10.1016/j.bvth.2025.100127)
Abstract
11.93 2
49 Inflammatory cytokines, inflammasomes, and neutrophil extrac… (10.1016/j.bvth.2025.100129)
Abstract
11.93 2
50 Idiopathic multicentric Castleman disease - TAFRO results in… (10.1016/j.bvth.2024.100006)
Abstract
7.53 1